Company / Financials
Avanos Medical, Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$701.2M
FY2025 · +1.9% YoY
Net Income
-$72.9M
FY2025 · +81.4% YoY
Profit Margin
-10.4%
FY2025 · net income / revenue
ROE
-9.4%
FY2025 · return on equity
Total Assets
$1.1B
FY2025
Total Debt
$90.3M
0.12x debt/equity
Equity
$778.2M
FY2025
ROA
-6.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$701.2M+1.9% YoYNet Income HistoryProfit after all expenses and taxes-$72.9M+81.4% YoYGross Profit HistoryRevenue minus cost of goods sold$353.9M-7.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$347.3M+13.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$61.6M+84.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$315.6M-0.9% YoYR&D Expense HistoryResearch and development spending$23.3M-11.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$15.0MIncome Tax HistoryTotal income tax expense$6.7M+139.4% YoYEPS (Basic) HistoryBasic earnings per share-$1.32-222.2% YoY